Novigenix
17.1.2024 08:02:15 CET | ACCESS Newswire | Press release
GENEVA, SWITZERLAND / ACCESSWIRE / January 17, 2024 / With cancer projected to escalate to 29 million cases by 2040[1], Novigenix, a pioneer in AI healthcare solutions, is rewriting the rules of cancer care. Their newest innovation, LITOSeek™, is primed to reshape drug development, offering a transformative leap forward.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Personalized Cancer Treatment: Breaking Barriers
Every cancer is as unique as the person it affects. Tumors are in continuous dynamic interplay with the patient's immune defenses and are adept at subverting and escaping immune control. Novigenix is on a mission to improve the cancer treatment landscape, leveraging advanced AI and RNA analysis from a routine blood draw to provide more precise insights into patient immune responses to cancer treatments, compared to conventional DNA liquid biopsies that evaluate tumor evolution through circulating tumor DNA (ctDNA). Insights into the precise dynamic of patient immune response thus pave the way for superior therapeutic discoveries in the field.
Empowering Biopharma: Unveiling LITOSeek™ at Precision Medicine World Conference
On January 24th at the Precision Medicine World Conference in Silicon Valley, Novigenix will debut LITOSeek™, a groundbreaking solution designed to expedite drug development for biopharma companies.
AI and RNA Analysis: Pioneering Healthcare Transformation
With a decade-long track record, Novigenix successfully launched Colox® blood test in Switzerland, powered by AI and RNA analysis to detect early-stage colon cancer, marking a significant departure from invasive colonoscopy procedures. By aggregating data from diverse colon cancer patients, Novigenix identified immune system biomarkers crucial for early-stage detection, enhancing treatment outcomes.
Dr. Brian Hashemi, Novigenix's CEO and Chairman, emphasized, "Our experience with Colox® underscores the potential of AI RNA analysis. Ongoing studies across various cancer types have fuelled our Knowledge Base to uncover comprehensive sets of biomarkers via liquid biopsy and AI RNA analysis. Our validated immunotherapy response biomarkers provide early prediction of patient response and we invite biopharma companies to leverage our platform for more efficient and effective drug development."
Professor Pedro Romero, M.D. Chief Medical & Scientific Officer of Novigenix, and Founding Chief Editor of the Journal of Immunotherapy of Cancer, highlights the importance of patient immune response in the development of novel therapies: "AI RNA analysis is poised to revolutionize healthcare, accelerating conventional experimental drug development with data-driven precision immune response prediction. By swiftly analyzing systemic immune responses, AI compresses analysis times, expediting traditional drug development and powering discovery of novel therapy targets."
A Team Dedicated to the Future of Cancer Care
With over 20 Ph.D.-level scientists focused on the development of the LITOSeek™ platform and advancing next-generation liquid biopsy solutions, Novigenix is pioneering precision immunology to help transform cancer treatment paradigms for better patient outcomes.
#Ends#
[1] https://canceratlas.cancer.org/the-burden/the-burden-of-cancer/
Contact Information
Edwin Shankar
edwin.shankar@leidar.com
SOURCE: Novigenix
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
American Wave Machines Files Patent Infringement Lawsuit Against WhiteWater West Industries2.10.2026 14:00:00 CEST | Press release
SOLANA BEACH, CA / ACCESS Newswire / October 2, 2026 / American Wave Machines, Inc. (AWM), the surf technology company behind PerfectSwell® Surf Venues worldwide, announced the filing of a patent infringement lawsuit against WhiteWater West Industries, Ltd. (WhiteWater). The lawsuit concerns WhiteWater's Endless Surf wave system, currently being installed at a surf park under construction in Fellsmere, Florida, and was filed in the United States District Court for the Southern District of Florida. AWM's President, Bruce McFarland, states "Surf venues thrive on originality, authenticity, and significant engineering investment. While we welcome the continued growth of the category, that growth must respect the intellectual property rights of those who pioneered this space. These legal actions are necessary to protect our patented technology, the investments behind it, and a fair and lawful marketplace for original inventors." The Innovation We're Protecting To understand what AWM is work
Datavault AI CEO to Present "Operating System for Tokenized Assets" at XRP Seoul 20262.10.2026 13:00:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / October 2, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that Nathaniel T. Bradley, CEO of Datavault AI, will present "Operating System for Tokenized Assets" at XRP Seoul 2026 on Oct. 3, 2026, at 3:05 p.m. KST at the Grand Hyatt Seoul in Seoul, South Korea. In the session, Bradley will explain why valuation, credentialing and verified metadata belong in a single operating layer beneath every real-world asset and how the Company's DataValue®, DataScore® and Information Data Exchange® technologies perform those functions in a single sequence beneath the point of issuance. "Tokenization gets treated as an issuance problem when it is really a data problem, and the Information Data Exchange exists to solve the data problem first," said Nathaniel T. Bradley, CEO of Datavault AI. "In Seoul,
GA-ASI Demonstrates Disaster Relief Comms System With SoftBank Corp.2.10.2026 04:00:00 CEST | Press release
SAN DIEGO, CA / ACCESS Newswire / October 1, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has completed a successful flight test using its MQ-9B Remotely Piloted Aircraft (RPA) featuring a new communications payload developed by SoftBank Corp., a major Japanese telecommunications and technology operator. The Disaster Relief Unit (DRU) communications pod can be used for disaster relief and recovery communications in areas where cellular service is not available. The pod was integrated onto an MQ-9B and flown by GA-ASI on July 27. DRU lets an MQ-9B serve as a mobile network relay tower in the sky. The aircraft can establish connectivity and communications in an area where cellular towers have been damaged - as, for example, by a flood or another natural disaster. "This is an exciting achievement for GA-ASI and SoftBank," said GA-ASI President David R. Alexander. "It's been a great experience working with SoftBank, and we believe this capability will be of interest to many o
Transoft Solutions Launches InSTRATO1.10.2026 20:30:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / October 1, 2026 / Transoft Solutions, a global leader in transportation engineering software and road safety solutions, has launched InSTRATO, a new web-based platform for transportation engineers, planners, and designers. This platform brings specialized transportation design tools together with new ways for professionals to share work, gather feedback, and collaborate throughout the project process. The launch marks the next chapter for AutoTURN Online, Transoft's web-based swept path analysis solution. AutoTURN Online will now be available within InSTRATO, continuing to provide the same trusted simulation technology and vehicle libraries users rely on today while opening the door to a broader set of transportation design and collaboration capabilities. "Since 2018, AutoTURN Online has helped more than 110,000 practitioners perform swept path analysis on the web, supporting design decisions that affect how people and vehicles move through the world.
ID TECH and SFEY Partner to Deliver Comprehensive Payment Solutions for Europe's Self-Service and Unattended Markets1.10.2026 19:00:00 CEST | Press release
CYPRESS, CA / ACCESS Newswire / October 1, 2026 / ID TECH, a global provider of secure payment solutions, today announced a strategic partnership with SFEY to deliver a comprehensive payment offering for the European self-service, unattended and transit market. The collaboration brings together ID TECH's industry-leading unattended payment hardware portfolio with SFEY's dynamic payment gateway and platform capabilities, creating an integrated solution designed to simplify deployment and accelerate time to market for system integrators across Europe. Together, the companies will support a broad range of unattended applications including self-service, kiosk, and transportation environments, with a scalable payment ecosystem built to meet evolving market requirements. A key area of focus within the partnership is support for mass transit and open-loop transit payment programs, leveraging SFEY's payment platform capabilities and certification expertise alongside ID TECH's transit-ready pay
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom